Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders
AssigneeBiopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka GmbH
InventorsMichael Paulista, Jens Pohl
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of cytokines of the TGF-β-superfamily as well as nucleic acids encoding said cytokines for the treatment and diagnosis of skin related disorders, including hair and gland related disorders in mammals.
Claims9
A method for improving wound healing and/or wound repair of skin tissue in a mammal, comprising administering an amount of a cytokine effective to improve wound healing and/or wound repair of skin tissue, wherein said cytokine is selected from the group consisting of GDF-5 or a part thereof wherein said part includes the 7 cysteine region and said GDF-5 or part thereof is modified by changing a cysteine required for dimer formation to another amino acid resulting in a monomeric cytokine and retains the wound healing and/or wound repair activity of the mature protein, to a mammal in need of wound healing or wound repair of skin tissue such that wound healing and/or wound repair of skin tissue is improved.
Dependencies are inferred from the claim text.